Outcomes Studies' Unsettling Questions
Executive Summary
That managed care, as an industry, has focused more on managing costs than on managing care only serves to point out how powerful the effective management of information can be. The new Jericho program launched by Cardinal Health Inc., the large drug distributor, combines drug dispensing technology with outcomes analysis. Jericho aims to help hospital pharmacists determine which of several competing branded drugs ultimately results in the best care.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.